Investing
Large tech-oriented companies have resumed their dominance during this year’s market recovery, so it isn’t much of a stretch to refer to a core...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
U.S. natural-gas supplies in storage marked their biggest weekly decline in nearly three years — but that wasn’t enough to rally prices for the...
Investing
Oil futures rose Thursday to settle at their highest prices since late November after government data showed larger-than-anticipated drops in U.S. crude inventories and...
Investing
Oil prices gave up early losses to finish higher on Friday — with production outages in the U.S., strong economic data and concerns about...
Investing
Topline The labor market continues to add jobs at a rapid clip even as many major employers keep slashing thousands of jobs, but a...
Investing
Large cryptocurrencies were mixed during morning trading on Monday, with Polygon MATICUSD, +3.45% seeing the biggest move, rising 2.80% to 69 cents. Solana SOLUSD,...
Investing
TL;DR The U.S. government is considering banning microchip exports to China, citing national security concerns It highlights a lesser known form of investing risk,...
Investing
Shares of Rivian Automotive Inc. powered up toward their best one-day gain in eight months Monday, after the electric vehicle maker announced second-quarter deliveries...
Investing
When investors seek portfolio diversification, they typically turn their attention to the equity market, probing for an over concentration of risk in a particular...
Investing
Key takeaways Headline PCE inflation was at 3.8%, the lowest result since 2021 However, core inflation only shifted to 4.6% and remains somewhat static...
Investing
By Yifan Wang Shares of Sinotruk and Weichai Power rallied after the companies issued positive profit alerts. Sinotruk, a Chinese heavy-duty truck maker, rose...
Investing
How do you build enough wealth to reach the ranks of the Forbes 400 Richest Americans? Eight of the greatest investors of all time...
Investing
By Mauro Orru Novartis’s generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S., effectively entering the country’s immunology...
